Bloomberg reports that Denmark-based vaginal mesh manufacturer Coloplast’s stock dropped the most in almost four years over concerns about lawsuits that patients injured by the implants have filed.
The story says a joint status conference is scheduled for lawsuits filed against vaginal mesh manufacturers including Coloplast, American Medical Systems Holdings Inc., CR Bard Inc. and Boston Scientific Corp.
The mesh implants are supposed to treat urinary incontinence and pelvic organ prolapse, which ...
continue reading...
A recent study indicates that the number of people suffering side effects after taking the cholesterol-lowering drugs known as statins is higher than previously reported, according to NPR.
According to the U.S. Environmental Protection Agency, federal regulations are in place that deal specifically with asbestos in schools.
The U.S. Food and Drug Administration has approved Johnson & Johnson’s drug Invokana, which will be used to treat type 2 diabetes.
A Los Angeles jury recently awarded $8.3 million in damages to a man who claimed he suffered metal poisoning from an artificial hip implant manufactured by Johnson & Johnson’s DePuy Orthopaedics division. That was the first of about 10,000 lawsuits over the hip implant to go to trial.
A story in Forbes says medical professionals and industry analysts are both keeping a close eye on Johnson & Johnson’s Invokana, newly approved by the U.S. Food and Drug Administration. It’s the first to be approved among a new class of medications that treat type 2 diabetes by reducing blood sugar, rather than affecting the supply or use of insulin.
